SCHEMBL7036801

SCHEMBL7036801

NC(Cc1ccc(F)cc1)c1ccc(OCc2ccccc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.57
MAOB P27338 6/20 0.54
GPR34 Q9UPC5 2/20 0.53
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C19 P33261 1/20 0.50
AR P10275 1/20 0.50
MEN1 O00255 1/20 0.50
ALDH1A1 P00352 1/20 0.50
RECQL P46063 1/20 0.50
KMT2A Q03164 1/20 0.50
APP P05067 1/20 0.50
LAP3 P28838 1/20 0.50
FFAR1 O14842 1/20 0.49
NR4A2 P43354 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9054167 0.93 LTA4H (0.65) LTA4HMAOBCYP1A2CYP2D6CYP2C19
Hydrochloric Acid SCHEMBL9054687 0.91 LTA4H (0.63) LTA4HMAOBCYP1A2CYP2D6CYP2C19
SCHEMBL8866173 0.91 LTA4H (0.62) LTA4HMAOBCYP1A2CYP2D6CYP2C19
SCHEMBL8866250 0.90 LTA4H (0.65) LTA4HMAOBCYP1A2CYP2D6CYP2C19
Hydrochloric Acid SCHEMBL8865569 0.90 LTA4H (0.60) LTA4HMAOBCYP1A2CYP2D6CYP2C19
Hydrochloric Acid SCHEMBL8866048 0.88 LTA4H (0.63) LTA4HMAOBCYP1A2CYP2D6CYP2C19
SCHEMBL3285416 0.84 EPHX1 (0.50) CYP1A2CYP2D6CYP2C19
Hydrochloric Acid SCHEMBL9205510 0.83 EPHX1 (0.48) CYP1A2CYP2D6CYP2C19
SCHEMBL3282141 0.81 CYP2D6 (0.47) CYP1A2CYP2D6CYP2C19MEN1KMT2A
SCHEMBL4337813 0.81 MEN1 (0.68) MAOBCYP1A2CYP2C19ARMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0659737-B1 Catecholamine surrogates useful as beta 3 agonists BRISTOL MYERS SQUIBB CO (US) 2003-03-26 EP disclosed
US-5776983-A ANTIDIABETIC AGENTS, OBESITY, GASTROINTESTINAL DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-07-07 US disclosed
EP-0659737-A2 Catecholamine surrogates useful as B3 agonists BRISTOL-MYERS SQUIBB COMPANY (US) 1995-06-28 EP disclosed